Free Trial
NYSE:HUM

Humana (HUM) Stock Price, News & Analysis

Humana logo
$247.28 +0.95 (+0.39%)
Closing price 05/7/2026 03:59 PM Eastern
Extended Trading
$246.06 -1.22 (-0.49%)
As of 09:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Humana Stock (NYSE:HUM)

Advanced

Key Stats

Today's Range
$239.65
$248.31
50-Day Range
$163.80
$247.28
52-Week Range
$163.11
$315.35
Volume
1.18 million shs
Average Volume
1.72 million shs
Market Capitalization
$29.69 billion
P/E Ratio
26.45
Dividend Yield
1.43%
Price Target
$247.61
Consensus Rating
Hold

Company Overview

Humana Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
90th Percentile Overall Score

HUM MarketRank™: 

Humana scored higher than 90% of companies evaluated by MarketBeat, and ranked 48th out of 860 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Humana has received a consensus rating of Hold. The company's average rating score is 2.12, and is based on no strong buy ratings, 7 buy ratings, 15 hold ratings, and 4 sell ratings.

  • Upside/Downside

    The consensus price target for Humana is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Humana has been the subject of 19 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Humana's stock forecast and price target.
  • Earnings Growth

    Earnings for Humana are expected to grow by 61.92% in the coming year, from $9.06 to $14.67 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Humana is 26.45, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.37.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Humana is 26.45, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.45.

  • Price to Earnings Growth Ratio

    Humana has a PEG Ratio of 2.27. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Humana has a P/B Ratio of 1.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.53% of the float of Humana has been sold short.
  • Short Interest Ratio / Days to Cover

    Humana has a short interest ratio ("days to cover") of 2.93, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Humana has recently decreased by 8.67%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Humana pays a meaningful dividend of 1.48%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Humana does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Humana is 37.86%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Humana will have a dividend payout ratio of 24.13% next year. This indicates that Humana will be able to sustain or increase its dividend.

  • Read more about Humana's dividend.
  • News Sentiment

    Humana has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 30 news articles for Humana this week, compared to 12 articles on an average week.
  • Search Interest

    26 people have searched for HUM on MarketBeat in the last 30 days. This is an increase of 37% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Humana to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Humana insiders have bought more of their company's stock than they have sold. Specifically, they have bought $150,020.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    0.20% of the stock of Humana is held by insiders.

  • Percentage Held by Institutions

    92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Humana's insider trading history.
Receive HUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HUM Stock News Headlines

Massive Data Leak Exposes 512,000-Line Code That Could Change Society Forever
"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent traveled to Lower Manhattan for a sit-down interview with 60-year Wall Street legend Marc Chaikin, she was shocked to discover that Marc had prepared a live demonstration of a technology that could change society forever. It involves NASA, the Department of Defense, huge banks – and a MAJOR AI upgrade that could add $400 trillion to the global economy.tc pixel
Humana (HUM) Gets a Hold from J.P. Morgan
See More Headlines

HUM Stock Analysis - Frequently Asked Questions

Humana's stock was trading at $256.35 at the start of the year. Since then, HUM shares have decreased by 3.5% and is now trading at $247.2840.

Humana Inc. (NYSE:HUM) posted its quarterly earnings data on Wednesday, April, 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. The business's revenue was up 23.5% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Humana: Enclara Healthcare, Kindred Healthcare, American Eldercare, FPG, Metropolitan Health Networks, Certify Data Systems, Harris Rothenberg International, and others.

Top institutional investors of Humana include Pzena Investment Management LLC (4.56%), Dimensional Fund Advisors LP (1.01%), Bank of New York Mellon Corp (0.51%) and SG Americas Securities LLC (0.34%). Insiders that own company stock include Sanjay K Shetty, Timothy S Huval and Jorge S Mesquita.
View institutional ownership trends
.

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Humana investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), American Water Works (AWK), AUO (AUOTY) and Triple Flag Precious Metals (TFPM).

Company Calendar

Record date for 4/24 Dividend
3/27/2026
Ex-Dividend for 4/24 Dividend
3/27/2026
Dividend Payable
4/24/2026
Last Earnings
4/29/2026
Today
5/08/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - HMO
Sub-Industry
Managed Health Care
Current Symbol
NYSE:HUM
CIK
49071
Employees
67,060
Year Founded
1961

Price Target and Rating

High Price Target
$344.00
Low Price Target
$146.00
Potential Upside/Downside
+0.1%
Consensus Rating
Hold
Rating Score (0-4)
2.12
Research Coverage
26 Analysts

Profitability

EPS (Trailing Twelve Months)
$9.35
Trailing P/E Ratio
26.45
Forward P/E Ratio
27.29
P/E Growth
2.27
Net Income
$1.19 billion
Net Margins
0.82%
Pretax Margin
1.06%
Return on Equity
10.45%
Return on Assets
3.75%

Debt

Debt-to-Equity Ratio
0.66
Current Ratio
1.77
Quick Ratio
1.77

Sales & Book Value

Annual Sales
$137.20 billion
Price / Sales
0.22
Cash Flow
$24.15 per share
Price / Cash Flow
10.24
Book Value
$155.30 per share
Price / Book
1.59

Miscellaneous

Outstanding Shares
120,062,000
Free Float
119,822,000
Market Cap
$29.69 billion
Optionable
Optionable
Beta
0.68

Social Links

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:HUM) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners